+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06659536

Post-Market Study on Cefar URO Device for Treating Urge Incontinence in Adults with Overactive Bladder Using P4 Program

Led by DJO UK Ltd · Updated on 2026-08-28

53

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and performance of the Cefar URO device using the preset program P4 for treating urge incontinence symptoms in adults with overactive bladder OAB, including refractory cases of idiopathic or neurogenic origin. This prospective clinical investigation aims to fill a data gap for the unique P4 program parameters of frequency 20Hz and pulse width 200bcs, which are commonly used but previously unstudied for this device. The study is conducted post-market to collect real-world evidence on device use at home. Participants will use the Cefar URO device at home for 12 weeks, applying transcutaneous posterior tibial nerve stimulation with the P4 program set at 20Hz frequency and 200bcs pulse width. Treatments last 30 minutes each, with patients recommended to perform seven sessions per week, totaling 84 treatments, but no fewer than one per week. Electrodes are placed on the medial ankle per device instructions. After the 12-week treatment period, a 4-week maintenance phase follows, where patients continue treatments as needed under investigator guidance without a fixed number of sessions. During the study, participants attend six onsite visits and receive ten weekly phone calls for follow-up and support. They complete questionnaires assessing OAB symptoms, quality of life, and treatment compliance at baseline, 6, 12, and 16 weeks including 4 weeks post-treatment. Researchers measure adverse events, symptom frequency, urinary urgency, and quality of life changes. The phone contacts help ensure adherence and timely reporting of any issues. Total participation spans approximately 16 weeks including treatment and follow-up.

CONDITIONS

Brief Title

Cefar URO - Symptomatic Treatment of Overactive Bladder

Research Team

V

Veronica Sebeo

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here